ABUS 8-K 2026-10-22

Arbutus Biopharma Corp (ABUS) 8-K dated 2026-10-22 — accession 0001171843-26-006753. This URL is the filing, not the ABUS hub.

Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.

Arbutus Biopharma Corp filed a 8-K on 2026-10-22. Accession 0001171843-26-006753.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ABUS revenue for 2025-12-31 was $14.1M. Net income was -$33.5M. Revenue was up 128.2% from 2024-12-31 to 2025-12-31. ABUS currently screens at market cap $883.0M.

Not investment advice. The ABUS SEC hub lists recent forms. The stock page is the research view.